Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More 03/05/15 San Francisco
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More 02/12/15 Seattle
End of Dendreon: Valeant’s $400M is Sole Offer, Purchase is Next 02/10/15 Seattle
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
Dendreon Gets $296M Bid From Valeant as Bankruptcy Auction Looms 01/30/15 Seattle
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” 12/02/14 National
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
West Coast Biotech Roundup: Intarcia, Dendreon, Amgen, Doudna & More 11/13/14 San Francisco
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy 11/10/14 Seattle
Former Dendreon CEO Gold Working on New Cancer Drug Startups 10/13/14 Wisconsin
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
Madison Startup Rides Immunotherapy Wave With Prostate Drug 08/18/14 Wisconsin
West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More 08/14/14 San Francisco
West Coast Biotech Roundup: Dendreon, Venter, Orexigen, & More 06/12/14 San Diego
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day 02/24/14 National
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
Report: Dendreon Looking to Get Acquired 10/26/13 Seattle
What Can Washington Do to Revitalize Biotech? Q&A With Gov. Inslee 10/25/13 Seattle
The $100M Club: Where the Major League Life Sciences Companies Are 10/14/13 National
Former Dendreon CEO and Dendreon Bull Start New Biotech Hedge Fund 09/03/13 Seattle
Dendreon Says Sales Will Decline in 2013, Shares Fall 08/08/13 Seattle
Page 1 of 12 next page »